Olfaction Disorders: Clinical Trials

5 trials for Olfaction Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Unknown 5

Follow Olfaction Disorders: new trials by email Literature Review of Olfaction Disorders trials Research Report on Olfaction Disorders

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Olfactory Performance in Culinary Arts Students
Olfactory training - Loss of Smell, Olfactory Disorder
Phase 4UnknownLeigh Sowerby1202023-09-252023-10-06
Investigating the Potential Role of Aerosolized Retinoic Acid, a Potent Vitamin A Metabolite for Treating COVID-19 Anosmia and Retinoic Acid Insufficiency .A Novel Approach for Regaining Sense of Smell.
Aerosolized 13 cis retinoic acid plus Vitamin D, Aerosolized All trans retinoic acid plus Vitamin D, Standard therapy - Post COVID-19 Anosmia (Loss of Smell)
Phase 4UnknownKafrelsheikh University100002021-11-012021-11-11
Influence of Olfaction Essential Oils on the Consumption of Benzodiazepine Receptor Agonists & Z-Drugs (BZRAs) Prescribed as " if Needed " in Psychiatric Outpatients (HECBA-PSY).
Essences and Essential Oils - Psychiatric Disorder, Benzodiazepine Withdrawal
Phase 4UnknownEtablissement Public de Santé Barthélemy Durand502021-04-192022-10-18
Anosmia and / or Ageusia and Early Corticosteroid Use
Early-Dexamethasone, Late dexamethazone - Covid19, Anosmia
Phase 4UnknownClinAmygate3002021-03-302023-09-06
A Study Assessing Change in Sense of Smell After Rasagiline Use in Parkinson's Patients
Rasagiline, Placebo - Parkinson's Disease
Phase 4UnknownThe Parkinson's Institute362009-11-012013-12-02

Narrower conditions

Anosmia (5)  ·  Anxiety Disorders (1)  ·  COVID-19 (1)  ·  Mental Disorders (1)  ·  Parkinson Disease (1)  ·  Sleep Initiation and Maintenance Disorders (1)

Broader conditions

Nervous System Diseases (5)  ·  Neurologic Manifestations (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Sensation Disorders (5)  ·  Signs and Symptoms (5)  ·  Basal Ganglia Diseases (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Dyssomnias (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Movement Disorders (1)

Interventions

Dexamethasone (1)  ·  Oils, Volatile (1)  ·  Olfactory Training (1)  ·  Standard of Care (1)  ·  Vitamin D (1)  ·  rasagiline (1)

Sponsors

ClinAmygate (1)  ·  Etablissement Public de Santé Barthélemy Durand (1)  ·  Kafrelsheikh University (1)  ·  Leigh Sowerby (1)  ·  The Parkinson's Institute (1)

Countries

Egypt (2)  ·  Canada (1)  ·  China (1)  ·  France (1)  ·  Saudi Arabia (1)  ·  United States (1)

Top investigators

Christian Trichard (1)  ·  Emad R Issak, MD (1)  ·  Grace S Liang, MD (1)  ·  Mahmoud Elkazzaz, M.Sc of Biochemistry (1)  ·  Tamer Haydara, Ass/Prof of Internal medicine (1)